Dermatology Times Chief Medical Editor Weighs in On Black Box Warning for JAK Inhibitors

In this exclusive video interview, Zoe Diana Draelos, MD, Dermatology Times chief medical editor, weighs in on the recent Black Box Warning issued by the FDA to certain JAK inhibitors.

Related Videos
infectious disease
Related Content

Q1 Accepted NDAs and sBLAs to Keep a Watchful Eye On

March 30th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists

March 10th 2023

Q1 Accepted NDAs and sBLAs to Keep a Watchful Eye On

March 30th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists

March 10th 2023

Q1 Accepted NDAs and sBLAs to Keep a Watchful Eye On

March 30th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists

March 10th 2023
© 2023 MJH Life Sciences

All rights reserved.